191 related articles for article (PubMed ID: 22815795)
1. Decreased expression of SATB2: a novel independent prognostic marker of worse outcome in laryngeal carcinoma patients.
Liu TR; Xu LH; Yang AK; Zhong Q; Song M; Li MZ; Hu LJ; Chen FJ; Hu ZD; Han P; Zeng MS
PLoS One; 2012; 7(7):e40704. PubMed ID: 22815795
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of SATB2 expression in patients with esophageal squamous cell carcinoma.
Geng GJ; Li N; Mi YJ; Yu XY; Luo XY; Gao J; Luo QC; Xie JD; Fa XE; Jiang J
Int J Clin Exp Pathol; 2015; 8(1):423-31. PubMed ID: 25755730
[TBL] [Abstract][Full Text] [Related]
3. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of cathepsin L: a novel independent prognostic marker of worse outcome in hepatocellular carcinoma patients.
Ruan J; Zheng H; Fu W; Zhao P; Su N; Luo R
PLoS One; 2014; 9(11):e112136. PubMed ID: 25384089
[TBL] [Abstract][Full Text] [Related]
5. Decreased SATB2 expression is associated with metastasis and poor prognosis in human clear cell renal cell carcinoma.
Guo C; Xiong D; Yao X; Gu W; Zhang H; Yang B; Peng B; Liu M; Zheng J
Int J Clin Exp Pathol; 2015; 8(4):3710-8. PubMed ID: 26097552
[TBL] [Abstract][Full Text] [Related]
6. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.
Mansour MA; Hyodo T; Ito S; Kurita K; Kokuryo T; Uehara K; Nagino M; Takahashi M; Hamaguchi M; Senga T
FEBS J; 2015 Apr; 282(8):1394-405. PubMed ID: 25662172
[TBL] [Abstract][Full Text] [Related]
7. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
Zheng Y; Duan L; Yang Y; Luo D; Yan B
Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer.
Wang S; Zhou J; Wang XY; Hao JM; Chen JZ; Zhang XM; Jin H; Liu L; Zhang YF; Liu J; Ding YQ; Li JM
J Pathol; 2009 Sep; 219(1):114-22. PubMed ID: 19557828
[TBL] [Abstract][Full Text] [Related]
9. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
[TBL] [Abstract][Full Text] [Related]
11. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 inhibits the growth of human laryngeal squamous cell carcinoma and down regulates EGFR-MAPKs signaling pathway.
Gu D; Li H; Wang Z; Chen Q; Jiang J; Zhu H
Laryngoscope; 2007 Oct; 117(10):1782-9. PubMed ID: 17906498
[TBL] [Abstract][Full Text] [Related]
13. Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma.
Mao Y; Zhang DW; Lin H; Xiong L; Liu Y; Li QD; Ma J; Cao Q; Chen RJ; Zhu J; Feng ZQ
J Exp Clin Cancer Res; 2012 Dec; 31(1):101. PubMed ID: 23231769
[TBL] [Abstract][Full Text] [Related]
14. A novel tumor suppressor CECR2 down regulation links glutamine metabolism contributes tumor growth in laryngeal squamous cell carcinoma.
Wang X; Xu C; Wang S; Huang W; Liu Y; Zhang X; Li N; Gao Z; Wang F; Zhang N; Guan J; Yi H; Liu F
Clin Transl Oncol; 2021 Sep; 23(9):1942-1954. PubMed ID: 33826083
[TBL] [Abstract][Full Text] [Related]
15. Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry.
Li JD; Chen Y; Jing SW; Wang LT; Zhou YH; Liu ZS; Song C; Li DZ; Wang HQ; Huang ZG; Dang YW; Chen G; Luo JY
Eur J Med Res; 2023 Dec; 28(1):591. PubMed ID: 38102653
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of UHRF1 is significantly associated with poor prognosis in laryngeal squamous cell carcinoma.
Pi JT; Lin Y; Quan Q; Chen LL; Jiang LZ; Chi W; Chen HY
Med Oncol; 2013 Dec; 30(4):613. PubMed ID: 24005809
[TBL] [Abstract][Full Text] [Related]
17. MiR-34a inhibits the proliferation, migration, and invasion of oral squamous cell carcinoma by directly targeting SATB2.
Ge X; Gao J; Sun QW; Wang CX; Deng W; Mao GY; Li HQ; Guo SS; Cheng J; Wu YN; Ye JH
J Cell Physiol; 2020 May; 235(5):4856-4864. PubMed ID: 31663131
[TBL] [Abstract][Full Text] [Related]
18. The Anti-tumor Activity and Mechanisms of rLj-RGD3 on Human Laryngeal Squamous Carcinoma Hep2 Cells.
Jin Y; Lv L; Ning SX; Wang JH; Xiao R
Anticancer Agents Med Chem; 2019; 19(17):2108-2119. PubMed ID: 31642792
[TBL] [Abstract][Full Text] [Related]
19. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.
Giotakis AI; Lazaris AC; Kataki A; Kontos CK; Giotakis EI
Cancer Biomark; 2019; 25(2):141-149. PubMed ID: 31104007
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis.
Wang Z; Huang C; Zhang A; Lu C; Liu L
Biomed Pharmacother; 2020 May; 125():109874. PubMed ID: 32014687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]